semaglutide diabetes Type 2 drug improves weight loss, blood sugar in certain Type 1 patients with obesity FDA Clears Semaglutide For Cardiac

Laub MC, Paetzke-Brunner I, Jaeger G: Serum carnitine during valproic acid therapy

for others, it fuels anxiety and dependency

Oral semaglutide is currently the only GLP-1 receptor agonist that has been approved by the FDA in tablet form for the treatment of weight loss

DOI: 10.1016/j.brainres.2015.07.005 36

Updated May 16, 2026 Reviewed by Lybi Ma Key points GLP-1 receptor agonists arent just for diabetes or obesitythey may treat cannabis abuse disorder

Again, the downsides of poorly controlled glucose and weight regain make this a poor approach to management since both hyperglycemia and increasing body mass index are associated with worse perioperative outcomes